Comparison of high-pressure liquid chromatography and microbiological assay for determination of ciprofloxacin tablets in human plasma employed in bioequivalence and pharmacokinetics study

Pakistan Journal of Pharmaceutical Sciences

Volumn 25, Issue 1, 2012, Pages 81-88

  Khan, Muhammad Khalid ^a   Khan, Muhammad Farid ^a   Mustafa, Ghulam ^a   Sualah, Mohammed ^b  

^a GOMAL UNIVERSITY   (Pakistan)

^b FEDERAL URDU UNIVERSITY OF ARTS   (Pakistan)

Author keywords

Bioequivalence; Ciprofloxacin; HPLC; Microbiological assay; Pharmacokinetics

Indexed keywords

CIPROFLOXACIN; DRUG METABOLITE;

ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; COMPARATIVE EFFECTIVENESS; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; MICROBIOLOGY; NORMAL HUMAN; SINGLE DRUG DOSE;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; DISK DIFFUSION ANTIMICROBIAL TESTS; HUMANS; MALE; TABLETS; THERAPEUTIC EQUIVALENCY;

EID: 84855403730     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Aliabadi FS and Lees P (1997). Pharmacodynamic and Pharmacokinetic inter-relationship of antibacterial drugs. J. Vet. Pharmacol. Ther., 20(Suppl.1): 14-17.
2. Arret B, Johnson DP and Kirshbaum A (1971). Outline of details for microbiological assays of antibiotics: Second revision. J. Pharm. Sci., 60: 1689-1694.
3. Borner K, Hoffken G, Lode H, Koeppe P, Prinzing C, Glatzel P. Wiley R, Olschewski P, Sievers B and Reinitz D (1986). Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur. J. Clin. Microbiol., 5(2): 179-186. (Pubitemid 16112914)
4. Bottner A, Schmid P and Hume R (1995). In vitro efficacy of cefquinone (INN) and other anti-infective drugs against bovine bacterial isolates from Belgium, France, Germany, The Netherlands, & the United Kingdom. J. Vet. Med. B. 42: 377-383.
5. Crump B, Wise R, and Dent J (1983). Pharmacokinetics andtissue penetration of ciprofloxacin. Antimicrob. Agents Chemother. 24:784-786.
6. Drusano GL, Johnson DE, Rosen M and Standiford HC (1993). Pharmacodynamics of a fluoroquinolones antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob. Agents Chemotherap., 37: 448-490.
7. Khan MK and Khan MF (2005). Extraction and separation of ciprofloxacin by HPLC from human plasma. Int. Chem. Med. J., 2(2): 267-270.
8. Nightingale CH, Grant EM and Quintiliani R (2000). Pharmacodynamics and pharmacokinetics of levofloxacin. Chemotherapy, 46(Suppl.1): 6-14. (Pubitemid 30248885)
9. Rao GS, Ramesh S, Ahmad AH, Tripathi HC, Shrama LD and Malik JK (2002) Disposition kinetics of enrofloxacin and ciprofloxacin following intravenous administration of enrofloxacin in goats. Small Ruminant Res., 44: 9-15. (Pubitemid 34452024)
10. Thomas M and File Jr (2001). Infectious diseases treatment updates-Fluoroquinolones. Clin. Infect. Sis., 15: 726-735.
11. Walker RC and Wright AJ (1987). The Quinolones. Mayo Clin. Proc., 62: 1007-1012. (Pubitemid 18045436)
12. Wingender W, Graefe W, Gau, D. Forster, D. Beermann and Schacht P (1984). Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers. Eur. J. Clin. Microbiol., 3: 355-359. (Pubitemid 14034601)
13. Ziegler R, Graefe K-H, Wingender W, Gau W, Zeiler HJ, Lietz U and Schacht P (1983). Program Abstr. Intersci. Conf.Antimicrob. Agents Chemother. 23rd, Las Vegas, Nev., Abstr. No. 851, 1983.